Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol vs Atenolol for Infantile Hemangioma
NCT02342275Phase 3Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Oct 2013
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of atenolol in infantile hemangioma (IH) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Any Response at 6 Months. Started Oct 2013; status: completed.
02
Drugs
atenolol
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT02342275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02342275.